These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19716651)

  • 1. Differential tumor-targeting abilities of three single-domain antibody formats.
    Bell A; Wang ZJ; Arbabi-Ghahroudi M; Chang TA; Durocher Y; Trojahn U; Baardsnes J; Jaramillo ML; Li S; Baral TN; O'Connor-McCourt M; Mackenzie R; Zhang J
    Cancer Lett; 2010 Mar; 289(1):81-90. PubMed ID: 19716651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.
    Behar G; Chames P; Teulon I; Cornillon A; Alshoukr F; Roquet F; Pugnière M; Teillaud JL; Gruaz-Guyon A; Pèlegrin A; Baty D
    FEBS J; 2009 Jul; 276(14):3881-93. PubMed ID: 19531051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of functional single domain antibody by whole cell immunization: implications for cancer treatment.
    Baral TN; Murad Y; Nguyen TD; Iqbal U; Zhang J
    J Immunol Methods; 2011 Aug; 371(1-2):70-80. PubMed ID: 21741385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of novel EGFR-specific VHH domains.
    Gottlin EB; Xiangrong Guan ; Pegram C; Cannedy A; Campa MJ; Patz EF
    J Biomol Screen; 2009 Jan; 14(1):77-85. PubMed ID: 19171923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of tumor cell-specific single-chain Fv from immunized mice using phage-antibody libraries and the re-construction of whole antibodies from these antibody fragments.
    Kettleborough CA; Ansell KH; Allen RW; Rosell-Vives E; Güssow DH; Bendig MM
    Eur J Immunol; 1994 Apr; 24(4):952-8. PubMed ID: 8149964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient expression and purification of chimeric heavy chain antibodies.
    Zhang J; Liu X; Bell A; To R; Baral TN; Azizi A; Li J; Cass B; Durocher Y
    Protein Expr Purif; 2009 May; 65(1):77-82. PubMed ID: 19007889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ⁹⁹mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study.
    Li C; Wen B; Wang L; Feng H; Xia X; Ding Z; Gao B; Zhang Y; Lan X
    Nucl Med Commun; 2015 May; 36(5):452-60. PubMed ID: 25591074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of chimeric heavy-chain antibodies.
    Zhang J; MacKenzie R; Durocher Y
    Methods Mol Biol; 2009; 525():323-36, xv. PubMed ID: 19252853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenol.
    Doyle PJ; Arbabi-Ghahroudi M; Gaudette N; Furzer G; Savard ME; Gleddie S; McLean MD; Mackenzie CR; Hall JC
    Mol Immunol; 2008 Aug; 45(14):3703-13. PubMed ID: 18632156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.
    Zhu Z; Rockwell P; Lu D; Kotanides H; Pytowski B; Hicklin DJ; Bohlen P; Witte L
    Cancer Res; 1998 Aug; 58(15):3209-14. PubMed ID: 9699643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Llama single domain antibodies as a tool for molecular mimicry.
    Zarebski LM; Urrutia M; Goldbaum FA
    J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor.
    Hyland S; Beerli RR; Barbas CF; Hynes NE; Wels W
    Oncogene; 2003 Mar; 22(10):1557-67. PubMed ID: 12629519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of antiricin single domain antibodies toward detection and therapeutic reagents.
    Anderson GP; Liu JL; Hale ML; Bernstein RD; Moore M; Swain MD; Goldman ER
    Anal Chem; 2008 Dec; 80(24):9604-11. PubMed ID: 19072267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating antibody-dependent cellular cytotoxicity of epidermal growth factor receptor-specific heavy-chain antibodies through hinge engineering.
    D'Eall C; Pon RA; Rossotti MA; Krahn N; Spearman M; Callaghan D; van Faassen H; Hussack G; Stetefeld J; Butler M; Durocher Y; Zhang J; Henry KA; Tanha J
    Immunol Cell Biol; 2019 Jul; 97(6):526-537. PubMed ID: 30680791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-chain antibody and its derivatives directed against vascular endothelial growth factor: application for antiangiogenic gene therapy.
    Afanasieva TA; Wittmer M; Vitaliti A; Ajmo M; Neri D; Klemenz R
    Gene Ther; 2003 Oct; 10(21):1850-9. PubMed ID: 12960975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentabody-mediated antigen delivery induces antigen-specific mucosal immune response.
    Li S; Zheng W; Kuolee R; Hirama T; Henry M; Makvandi-Nejad S; Fjällman T; Chen W; Zhang J
    Mol Immunol; 2009 May; 46(8-9):1718-26. PubMed ID: 19269688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule.
    Friedman M; Orlova A; Johansson E; Eriksson TL; Höidén-Guthenberg I; Tolmachev V; Nilsson FY; Ståhl S
    J Mol Biol; 2008 Mar; 376(5):1388-402. PubMed ID: 18207161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.